In the present dose and schedule, the authors found hexamethylmelamine to be ineffective in the management of metastatic breast cancer already refractory to standard chemotherapy and hormonal therapeutic approaches in 19 cases.
|Original language||English (US)|
|Number of pages||3|
|Journal||Cancer Treatment Reports|
|State||Published - Jan 1 1978|
ASJC Scopus subject areas
- Cancer Research